AGENUS INC (AGEN)
US00847G8042 - Common Stock
These stocks are moving in today's session
Friday's session: top gainers and losers
Commit To Purchase Agenus At $1, Earn 2607.1% Annualized Using Options
Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps.
Let's have a look at the gap up and gap down stocks in today's session.
Let's take a look at the stocks that are in motion in today's session.
Top movers in Monday's session
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.
The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start the trading week with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!
Down 75%. Is Agenus Stock a Buy on the Dip?
Wall Street analysts who watch the cancer drug developer closely think it could rocket higher.
Agenus Announces Reverse Stock Split of Common Stock
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?
These stocks could rocket higher, but they also present significant risks.
3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 Million
If you want the chance at possible absurd returns, then consider gambling on these stocks to turn $1,000 into $1 million.
Agenus (AGEN) Q4 2023 Earnings Call Transcript
AGEN earnings call for the period ending December 31, 2023.
Agenus Reports Fourth Quarter and Full Year 2023 Results
Agenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024
Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report
Agenus to Participate in Leerink Partners Global Biopharma Conference
Why Agenus Stock Plummeted by Nearly 30% on Its Stock Split News Today
The company hopes to engineer a 1-for-20 reverse stock split.
Ginkgo stock gains after $31M contract win with Agenus
SaponiQx, a unit of Agenus (AGEN), and Ginkgo Bioworks (DNA) have won a multi-year contract worth up to $31M to sudy vaccine adjuvants. Read more here.
Ginkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular Design
/PRNewswire/ -- The Defense Threat Reduction Agency's (DTRA) Joint Science and Technology Office (JSTO) for the Chemical and Biological Defense (CBD) Program...
Moderna RSV vaccine lags rival shots in long-term efficacy
TD Cowen argues that Moderna's (MRNA) upcoming mRNA-based RSV vaccine has a faster decline in efficacy compared to rival shots from Pfizer (PFE) and GSK (GSK). Read more here.
GSK RSV shot under FDA priority review for label expansion
GSK's respiratory syncytial virus (RSV) vaccine, Arexvy, is under priority review by the FDA for a label expansion to age group 50-59. Read more here.
7 Analyst-Backed Stocks With Promising 10-Bagger Potential
Although true 10-baggers are by nature extremely difficult to come by, these analyst-backed stocks may offer a decent shot.
Agenus to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference
GSK Q4 to spotlight vaccine business amid Arexvy rollout
GSK's (GSK) Q4 2023 results are exected to highlight its vaccine division amid the ongoing early market rollout of its RSV vaccine, Arexvy. Read more here.
3 Biotech Stocks with Potential for Major Medical Breakthroughs in 2024
There are several potential biotech breakthroughs likely to occur in 2024, and these three biotech stocks could see substantial gains
Agenus stock up 7% on positive data for colorectal cancer drugs (NASDAQ:AGEN)
Agenus (AGEN) stock climbed 7% after the company announced positive results from a study of the drug combination botensilimab and balstilimab in the treatment of colorectal cancer.
Commit To Purchase Agenus At $0.50, Earn 30% Using Options
Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Agenus to Participate in B. Riley Healthcare Conference
2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street
These two biotech stocks could be poised for a trend reversal.
